Cross-trial validation of molecular subtypes in patients with metastatic clear cell renal cell carcinoma (RCC): The JAVELIN Renal 101 experience Meeting Abstract
| Authors: | Saliby, R. M.; Jammihal, T.; Labaki, C.; Xie, W.; Motzer, R. J.; Powles, T.; Rini, B. I.; Albiges, L.; Pal, S. K.; McKay, R. R.; Signoretti, S.; Shukla, S. A.; Van Allen, E. M.; Braun, D. A.; Choueiri, T. K. |
| Abstract Title: | Cross-trial validation of molecular subtypes in patients with metastatic clear cell renal cell carcinoma (RCC): The JAVELIN Renal 101 experience |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301351 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.4531 |
| Notes: | Meeting Abstract: 4531 -- Meeting also held virtually -- Source: Wos |
